Inflammation in multiple sclerosis: the good, the bad, and the complex.
about
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsPercutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsNatalizumab for relapsing remitting multiple sclerosisThe big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosisImaging Neuroinflammation - from Bench to Bedside.Anomalous venous blood flow and iron deposition in multiple sclerosis.Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat.Neurorestorative effect of urinary bladder matrix-mediated neural stem cell transplantation following traumatic brain injury in rats.Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Cannabinoids and neuroinflammation.Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosisCytokine-based immunointervention in the treatment of autoimmune diseases.On the horizon: possible neuroprotective role for glatiramer acetate.Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effectsGlatiramer acetate in multiple sclerosis.Cannabinoid CB2 receptors in human brain inflammation.The P66Shc/mitochondrial permeability transition pore pathway determines neurodegeneration.Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone.The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey.Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells.Adduction of cholesterol 5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope.Immunity and inflammation in neurodegenerative diseases.Composite MR Contrast Agents for Conditional Cell-Labeling.Inflammatory biomarkers in blood of patients with acute brain ischemia.Inhibition of Rho-dependent pathways by Clostridium botulinum C3 protein induces a proinflammatory profile in microglia.Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis.Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of ?765G>C with disease risk
P2860
Q24202111-7A9075DA-F634-482E-8CF9-C93F18FCA65EQ24202967-AB20FA2D-48E9-4D66-AFCC-66913A3F5D68Q24235861-F2C2F5FA-5F01-4756-94C8-C50862A70F0BQ24675908-54525F4F-898F-4D48-912B-21B2B1E42A0EQ30881154-598CC18E-D783-4781-ADF9-D482A840CEC0Q33499203-A5A1BB4F-0B49-4766-BD8A-80FFB436E209Q33697723-C13CA8BF-E14E-41BF-9CC4-E835129DD254Q33724891-BBB5854B-4F92-4ACA-8330-74ED4E31D4C3Q34003724-C4D1545E-2CFA-4CA7-A580-12D4FD565769Q34784469-5F1E341B-C0DD-4818-AECE-6D926F206C0EQ35046205-118DD934-BB86-495A-AFA2-42CE11E485F5Q35070143-546D2F3A-AA88-4641-A075-DCA23581D05EQ35109131-85206D8C-02E4-4945-8C61-70765F57944EQ35818185-8E549FD2-9C7D-48F9-B831-1D82D350009EQ35903755-5729843D-C7DC-483F-9550-239C990CD575Q36022796-95927E0E-A9D0-4EB5-B82C-80F3057B8E36Q36198583-52E64A1C-48EF-4DCE-8A30-CD3AC745AF48Q36416377-3A5E43DC-65AC-47D6-8551-66C818E52B52Q36898560-2A2F84CF-4947-4584-8FAB-0CA504B4D100Q37266710-E9AF59E8-E9A8-40D2-B76D-986C1B25D5AFQ37635764-C20EFC0D-7E93-4B62-9BEA-E8F6961A63D4Q37684368-EAC678AA-A442-4710-B3B0-3B56EAE4856AQ37906358-C77D19A5-6B54-493B-BA64-881AB4EEA040Q40384271-0A1A33D5-C2AD-4165-8556-5C10DD44096FQ42425194-FA2C9FB3-CFE9-4E66-85C8-95B73F388E11Q42702452-982C1274-3EDD-4521-9D62-B4BD0F9CBCECQ43104143-D157FCEF-E0DF-4F6E-81F3-F5981EBFFBACQ43194853-9097B199-7A96-4DAC-A219-D9922F96F214Q44894573-DB7785DF-B440-4E63-9738-1F99593D55F5Q46622473-520BD900-7335-4AAD-9A7A-D6E7193DD92CQ47383776-4DDDD137-88CE-49A3-98F1-C865A651E5FEQ50773267-9AE97C1F-EBE5-49FD-9570-F6AF36DCA8AEQ58885887-6ED6977A-2066-41BB-9D3A-F8078C07CC7A
P2860
Inflammation in multiple sclerosis: the good, the bad, and the complex.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@ast
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@en
type
label
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@ast
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@en
prefLabel
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@ast
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@en
P2093
P1433
P1476
Inflammation in multiple sclerosis: the good, the bad, and the complex.
@en
P2093
Boris Kallmann
Gianvito Martino
Jan Hillert
Luciano Adorini
Massimo Filippi
Peter Rieckmann
P304
P356
10.1016/S1474-4422(02)00223-5
P577
2002-12-01T00:00:00Z